# Combined Use of Cyclosporine and Metformin in Treatment of Psoriasis vs Cyclosporine Alone

> **NCT07375654** · PHASE1 · COMPLETED · sponsor: **Cairo University** · enrollment: 32 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Cyclosporin (CSA)
- **DRUG:** Metformin (500 mg Twice a day)

## Key facts

- **NCT ID:** NCT07375654
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-19
- **Primary completion:** 2025-10-04
- **Final completion:** 2025-11-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07375654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07375654, "Combined Use of Cyclosporine and Metformin in Treatment of Psoriasis vs Cyclosporine Alone". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07375654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*